Alpha Dna Investment Management LLC Ocular Therapeutix, Inc Transaction History
Alpha Dna Investment Management LLC
- $250 Million
- Q2 2024
Shares
3 transactions
Others Institutions Holding OCUL
# of Institutions
151Shares Held
136MCall Options Held
86.4KPut Options Held
263K-
Summer Road LLC West Palm Beach, FL14.9MShares$129 Million98.56% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$111 Million9.58% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.7MShares$110 Million2.86% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$100 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.61MShares$74.8 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $668M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...